Weight Loss Medication Study for People with T2D

Now Enrolling Adults Ages 18 and Older

Now Enrolling

About this research study

Obesity is associated with an increased risk of developing hypertension, cardiovascular (CV) disease, obstructive sleep apnea, and many other medical conditions. Losing weight with lifestyle changes can be difficult to maintain long term, and weight-loss surgeries can present with major risks.

Velocity is conducting a clinical research study for overweight people with type 2 diabetes for an investigational medication for obesity.

Eligible participants...

  • Must be age 18 or older
  • Must have a BMI at least 27 kg/m2
  • Must have been diagnosed with type 2 diabetes for 180 days or more
  • Must have previously attempted to lose weight unsuccessfully
  • May receive compensation for study-related time
  • Do not need insurance to join this study

For more information, complete the form on this page. After you submit your information, a Velocity enrollment specialist will call you to talk about the study. There is no obligation to participate — you can decide if the study is right for you.

Enter your info

Name(Required)
Date of birth(Required)
Age can help us determine study eligibility (you must be age 18 or older to submit this form).
Race(Required)
Select one or more designations that best describe you. This information can help Velocity better ensure all populations are represented in research.
This field is hidden when viewing the form

By entering your email address and/or phone number on this form, you represent that you are at least 18 years of age and consent to receiving communications (e.g., call, SMS, text, and/or email) from Velocity and/or the research site(s) involved with the clinical trials that appear on this website. Messaging frequency varies. Message and data rates may apply. You may reply with STOP to a text message. For any help regarding messaging, please email us at info@velocityclinical.com. For full details, refer to Velocity's privacy policy and website terms of use. Submissions on this website are not monitored 24/7. Do NOT submit personal health or medical information on this form. If you are enrolled in a trial and have questions, please call your research site.

This field is for validation purposes and should be left unchanged.

Study Locations

Sioux City, Iowa • Velocity Clinical Research

4802 Sunnybrook Drive, Sioux City, IA 51106
Phone: (712) 639-6300

Valparaiso, Indiana • Velocity Clinical Research

55 University Drive, Suite 106, Valparaiso, IN 46383
Phone: (219) 464-8302

Vestal, New York • Velocity Clinical Research

4100 Vestal Road, Ste LL-100, Vestal, NY 13850
Phone: (607) 794-5790

©2023 Velocity Clinical Research | All Rights Reserved | Privacy Policy